(redirected from blueprint)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia.
B/PBrain/Plasma Ratio (biopharmaceutics)
B/P(Seat)Belts - Passive (door mounted)
References in periodicals archive ?
Four years after the Blueprint was unveiled, Mace now has plans either in place, or in development, for more than 20 categories
Mark Levin, partner, Third Rock Ventures and board member, Blueprint Medicines added, "While we are sad to lose Chris at Third Rock, the appointment of Chris to CEO of Blueprint Medicines is an excellent example of our approach to building great companies with the best talent.
Initiated Phase 1 clinical trials for BLU-285 and BLU-554 : Blueprint Medicines is enrolling patients in dose-escalation, Phase 1 clinical trials of BLU-285 for the treatment of unresectable, treatment-resistant gastrointestinal stromal tumors (GIST) and BLU-554 for the treatment of advanced hepatocellular carcinoma (HCC) and cholangiocarcinoma.
The DNS security service from BluePrint Data is less expensive to end users has a larger margin for IT providers and resellers such as Value Added Resellers (VARs) and Managed Service Providers (MSPs).
Launched in February 2013, the Blueprint is now in its legacy phase, and the forum this week will be the first step in taking the findings of the Blueprint and turning them into real, tangible actions.
Prior to joining Blueprint Capital, Fuller held senior executive positions at US Bank, Sterling Savings Bank and Golf Savings Bank.
The new preclinical data presented by Blueprint Medicines at ILCA further validate the advancement of BLU-554 into clinical development.
About Blueprint Medicines Blueprint Medicines makes kinase drugs to treat patients with genomically defined diseases.
BluePrint Data's "Zero False Positive Guarantee" program will credit new customers who sign up under this program in October with a $500 credit for each separate occurrence[1] where the customer's end user is disallowed access to a website because BluePrint Data has incorrectly categorized it.
The requirements definition and management software market is at a tipping point for explosive growth over the next two to three years as Business and IT leaders embrace powerful platforms like Blueprint that improve business and IT collaboration and finally close this major gap in the software development process that is costing the industry over $100B annually in waste and rework.
In this Phase 1 trial, Blueprint Medicines plans to enroll approximately 60 patients with advanced SM, which includes aggressive SM with associated hematological non-mast cell disorders (SM-AHNMD) and mast cell leukemia (MCL), and other relapsed or refractory myeloid malignancies at multiple sites in Europe and the United States.